Eurofins Genomics Denmark A/S: Financial statements 2012
CVR: 10048818
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Eurofins Genomics Denmark A/S (CVR 10048818) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 22,504,216 and a net result of DKK 3,393,255. Equity in the 2012 report amounted to DKK 14,869,704. The solvency ratio was 32.3%.
- Gross Profit
- DKK 22,504,216
- Profit/Loss
- DKK 3,393,255
- Equity
- DKK 14,869,704
- Total Assets
- DKK 46,107,124
Official annual report
Keep an eye on Eurofins Genomics Denmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of Eurofins Genomics Denmark A/S.
About Eurofins Genomics Denmark A/S
Eurofins Genomics Denmark A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Eurofins Genomics Europe AgriGenomics Products & Services A/S and Eurofins Genomics Europe Genotyping A/S. The management consists of Jacob Sickmann Ransborg. The board consists of Svend Aage Linde (chair), Jacob Sickmann Ransborg and Ulrich August Werner Kühle. The company is owned by Eurofins Genomics LUX Holding SARL. The company has 68 employees (2026). In 2025, the company reported a gross profit of DKK 43,634,455 and a net result of DKK -8,643,885 compared with DKK -12,812,295 the year before. Equity in the 2025 report amounted to DKK 14,211,619.
